Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution

Cancer statistics, 2014

Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499 · see citing works

Molecular determinants of resistance to antiandrogen therapy

Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278 · see citing works

Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

Montgomery, R. B., Mostaghel, E. A., Vessella, R., Hess, D. L., Kalhorn, T. F., Higano, C. S., True, L. D., & Nelson, P. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0249 · Cited by 1,419 · see citing works

Androgen Deprivation Therapy for Prostate Cancer

Sharifi, N. (2005) · JAMA · doi:10.1001/jama.294.2.238 · Cited by 1,087 · see citing works

Glucuronidation of Drugs and Other Compounds

Dutton, G. J. (2019) · Chapman & Hall/CRC eBooks · doi:10.1201/9780429264177 · Cited by 804 · see citing works

Androgen Levels Increase by Intratumoral <i>De novo</i> Steroidogenesis during Progression of Castration-Resistant Prostate Cancer

Locke, J. A., Guns, E. S., Lubik, A. A., Adomat, H. H., Hendy, S. C., Wood, C. A., Ettinger, S. L., Gleave, M. E., & Nelson, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5997 · Cited by 747 · see citing works

Intracrinology

Labrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685 · see citing works

Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines

Li, Y.-M., Chan, S.-C., Brand, L., Hwang, T., Silverstein, K., & Dehm, S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-3630 · Cited by 663 · see citing works

Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants

Mostaghel, E. A., Marck, B. T., Plymate, S. R., Vessella, R. L., Balk, S. P., Matsumoto, A. M., Nelson, P. S., & Montgomery, B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0728 · Cited by 583 · see citing works

Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer

Mostaghel, E. A., Page, S. T., Lin, D. W., Fazli, L., Coleman, I. M., True, L. D., Knudsen, B., Hess, D. L., Nelson, C. C., Matsumoto, A. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3332 · Cited by 529 · see citing works

STRUCTURAL AND FUNCTIONAL STUDIES OF UDP-GLUCURONOSYLTRANSFERASES*

Radominska-p, A., Czernik, P. J., Little, J. M., Battaglia, E., & Mackenzie, P. I. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101944 · Cited by 497 · see citing works

The program of androgen-responsive genes in neoplastic prostate epithelium

Nelson, P. S., Clegg, N. J., Arnold, H., Ferguson, C., Bonham, M. J., White, J., Hood, L., & Lin, B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182376299 · Cited by 483 · see citing works

The intranuclear binding of testosterone and 5α-androstan-17β-ol-3-one by rat prostate

Bruchovsky, N., & Wilson, J. D. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94513-8 · Cited by 404 · see citing works

Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence

Taplin, M., & Balk, S. P. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10653 · Cited by 392 · see citing works

AR, the cell cycle, and prostate cancer

Balk, S. P., & Knudsen, K. E. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06001 · Cited by 338 · see citing works

Relative Enzymatic Activity, Protein Stability, and Tissue Distribution of Human Steroid-Metabolizing UGT2B Subfamily Members**This work was supported by the Medical Research Council of Canada, the Fonds de la Recherche en Sante du Quebec, and Endorecherche.

Turgeon, D., Carrier, J.-S., Lévesque, E., Hum, D. W., & Bélanger, A. (2001) · Endocrinology · doi:10.1210/endo.142.2.7958 · Cited by 333 · see citing works

Mechanisms of the androgen receptor splicing in prostate cancer cells

Liu, L. L., Xie, N., Sun, S., Plymate, S. R., Mostaghel, E. A., & Dong, X. (2013) · Oncogene · doi:10.1038/onc.2013.284 · Cited by 313 · see citing works

Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development

Cunha, G. R., Ricke, W. A., Thomson, A. A., Marker, P. C., Risbridger, G. P., Hayward, S. W., Wang, Y. Z., Donjacour, A. A., & Kurita, T. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.10.017 · Cited by 310 · see citing works

Hormonal Predictors of Prostate Cancer: A Meta-Analysis

Shaneyfelt, T. M., Husein, R., Bubley, G. J., & Mantzoros, C. S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.847 · Cited by 309 · see citing works

Large Differences in Testosterone Excretion in Korean and Swedish Men Are Strongly Associated with a UDP-Glucuronosyl Transferase 2B17 Polymorphism

Jakobsson, J., Ekström, L., Inotsume, N., Garle, M., Lorentzon, M., Ohlsson, C., Roh, H., Carlström, K., & Rane, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1643 · Cited by 282 · see citing works

New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.

Labrie, F., Dupont, A., Bèlanger, A., Cusan, L., Lacourcière, Y., Monfette, G., LaBerge, J., Emond, J., Fazekas, A. T. A., Raynaud, J., et al. (1982) · PubMed · Cited by 276 · see citing works

STRUCTURE AND FUNCTION OF URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASES

Meech, R., & Mackenzie, P. I. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb02718.x · Cited by 267 · see citing works

GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE

Wells, P. G., Mackenzie, P. I., Roy Chowdhury, J., Guillemette, C., Gregory, P. A., Ishii, Y., Hansen, A. J., Kessler, F. K., Kim, P. M., Roy Chowdhury, N., et al. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.281 · Cited by 260 · see citing works

A Genome-Wide Association Meta-Analysis of Circulating Sex Hormone–Binding Globulin Reveals Multiple Loci Implicated in Sex Steroid Hormone Regulation

Coviello, A. D., Haring, R., Wellons, M., Vaidya, D., Lehtimäki, T., Keildson, S., Lunetta, K. L., He, C., Fornage, M., Lagou, V., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002805 · Cited by 250 · see citing works

Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases

Zhang, X., Morrissey, C. M., Sun, S., Ketchandji, M., Nelson, P. S., True, L. D., Vakar‐Lopez, F., Vessella, R. L., & Plymate, S. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027970 · Cited by 240 · see citing works

Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans

Bélanger, A., Pelletier, G., Labrie, F., Barbier, O., & Chouinard, S. (2003) · Trends in Endocrinology &amp; Metabolism · doi:10.1016/j.tem.2003.10.005 · Cited by 235 · see citing works

Isolation and characterization of UGT2B15(Y85): a UDP glucuronosyltransferase encoded by a polymorphic gene

Lévesque, É., Beaulieu, M., Green, M. D., Tephly, T. R., Bélanger, A., & Hum, D. W. (1997) · Pharmacogenetics · doi:10.1097/00008571-199708000-00007 · Cited by 218 · see citing works

Hormones and prostate cancer: Current perspectives and future directions

Hsing, A. W., Reichardt, J. K. V., & Stanczyk, F. Z. (2002) · The Prostate · doi:10.1002/pros.10108 · Cited by 208 · see citing works

THE RESULTS OF DOUBLE CASTRATION IN HYPERTROPHY OF THE PROSTATE

WHITE, J. W. (1895) · Annals of Surgery · doi:10.1097/00000658-189507000-00001 · Cited by 194 · see citing works

Transcriptional programs activated by exposure of human prostate cancer cells to androgen

DePrimo, S. E., Diehn, M., Nelson, J. B., Reiter, R. E., Matese, J. C., Fero, M., Tibshirani, R. J., Brown, P. O., & Brooks, J. D. (2002) · Genome biology · doi:10.1186/gb-2002-3-7-research0032 · Cited by 193 · see citing works

Isolation and Characterization of a Novel cDNA Encoding a Human UDP-Glucuronosyltransferase Active on C19 Steroids

Beaulieu, M., Lávesque, E., Hum, D. W., & Bálanger, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22855 · Cited by 187 · see citing works

New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway

Attard, G., Richards, J., & Bono, J. S. D. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0567 · Cited by 184 · see citing works

Gonadotropin-Releasing Hormone Agonists in the Treatment of Prostate Cancer

Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., Cusan, L., Gomez, J., & Candas, B. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0017 · Cited by 169 · see citing works

Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15

Wilson, W., de Villena, F. P., Lyn‐Cook, B. D., Chatterjee, P. K., Bell, T. A., Detwiler, D. A., Gilmore, R. C., Valladeras, I. C., Wright, C. C., Threadgill, D. W., et al. (2004) · Genomics · doi:10.1016/j.ygeno.2004.06.011 · Cited by 155 · see citing works

Secondary Hormonal Therapy for Advanced Prostate Cancer

Lam, J. S., Leppert, J. T., Vemulapalli, S. N., Shvarts, O., & Belldegrun, A. S. (2006) · Journal of Urology · doi:10.1016/s0022-5347(05)00034-0 · Cited by 153 · see citing works

UGT genomic diversity: beyond gene duplication

Guillemette, C., Lévesque, É., Harvey, M., Bellemare, J., & Ménard, V. (2009) · Drug Metabolism Reviews · doi:10.3109/03602530903210682 · Cited by 134 · see citing works

Castration-resistant prostate cancer: Adaptive responses in the androgen axis

Egan, A., Dong, Y., Zhang, H., Qi, Y., Balk, S. P., & Sartor, O. A. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.09.011 · Cited by 125 · see citing works

Evaluation of Genetic Variations in the Androgen and Estrogen Metabolic Pathways as Risk Factors for Sporadic and Familial Prostate Cancer

Cunningham, J. M., Hebbring, S. J., McDonnell, S. K., Cicek, M. S., Christensen, G. B., Wang, L., Jacobsen, S. J., Cerhan, J. R., Blute, M. L., Schaid, D. J., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0767 · Cited by 120 · see citing works

Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase

Jedlitschky, G., Cassidy, A., Sales, M., Pratt, N. R., & Burchell, B. (1999) · Biochemical Journal · doi:10.1042/bj3400837 · Cited by 118 · see citing works

UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells

Chouinard, S., Barbier, O., & Bélanger, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703370200 · Cited by 109 · see citing works

Regulation of the UGT1A1 bilirubin-conjugating pathway: Role of a new splicing event at the UGT1A locus

Lévesque, É., Girard, H., Journault, K., Lépine, J., & Guillemette, C. (2006) · Hepatology · doi:10.1002/hep.21464 · Cited by 96 · see citing works

Androgen Receptor Splice Variant AR3 Promotes Prostate Cancer via Modulating Expression of Autocrine/Paracrine Factors

Sun, F., Chen, H.-G., Li, W., Yang, X., Wang, X., Jiang, R., Guo, Z., Chen, H., Huang, J., Borowsky, A. D., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.492140 · Cited by 93 · see citing works

Genetic diversity at the UGT1 locus is amplified by a novel 3′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity

Girard, H., Lévesque, É., Bellemare, J., Journault, K., Caillier, B., & Guillemette, C. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f1f118 · Cited by 93 · see citing works

Inactivation by UDP-glucuronosyltransferase enzymes: The end of androgen signaling

Chouinard, S., Yueh, M.-F., Tukey, R. H., Giton, F., Fiet, J., Pelletier, G., Barbier, O., & Bélanger, A. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.03.016 · Cited by 90 · see citing works

An Allele-Specific Polymerase Chain Reaction Method for the Determination of the D85Y Polymorphism in the Human UDPGlucuronosyltransferase 2B15 Gene in a Case-Control Study of Prostate Cancer

MacLeod, S. L., Nowell, S. A., Plaxco, J., & Lang, N. P. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0777-3 · Cited by 88 · see citing works

Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate

Barbier, O., & Bélanger, A. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.01.001 · Cited by 86 · see citing works

Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk

Gsur, A. (2002) · Carcinogenesis · doi:10.1093/carcin/23.10.1647 · Cited by 85 · see citing works

Androgen receptor mediates the expression of UDP‐glucuronosyltransferase 2 B15 and B17 genes

Bao, B., Chuang, B., Wang, Q., Sartor, O., Balk, S. P., Brown, M. A., Kantoff, P. W., & Lee, G. M. (2008) · The Prostate · doi:10.1002/pros.20749 · Cited by 78 · see citing works

Chromosomal Localization, Structure, and Regulation of the UGT2B17 Gene, Encoding a C19 Steroid Metabolizing Enzyme

BEAULIEU, M., Lévesque, É., Tchernof, A., Beatty, B., Bélanger, A., & Hum, D. W. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.1143 · Cited by 77 · see citing works

ASP85TYR POLYMORPHISM IN THE UDP-GLUCURONOSYLTRANSFERASE (UGT) 2B15 GENE AND THE RISK OF PROSTATE CANCER

Park, J. M., Chen, L., Shade, K., Lazarus, P. J., Seigne, J. D., Patterson, S. G., Helal, M. A., & Pow‐Sang, J. M. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000117748.44313.43 · Cited by 76 · see citing works

Endocrine Control of Prostatic Cancer

Huggins, C. (1943) · Science · doi:10.1126/science.97.2529.541 · Cited by 68 · see citing works

Deletions of the Androgen-MetabolizingUGT2BGenes Have an Effect on Circulating Steroid Levels and Biochemical Recurrence after Radical Prostatectomy in Localized Prostate Cancer

Nadeau, G., Bellemare, J., Audet‐Walsh, É., Flageole, C., Huang, S., Bao, B., Douville, P., Caron, P., Fradet, Y., Lacombe, L., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1049 · Cited by 58 · see citing works

Cellular Specific Expression of the Androgen‐Conjugating Enzymes UGT2B15 and UGT2B17 in the Human Prostate Epithelium

Chouinard, S., Pelletier, G., Bélanger, A., & Barbier, O. (2004) · Endocrine Research · doi:10.1081/erc-200044014 · Cited by 57 · see citing works

Therapeutic options for hormone-refractory prostate cancer in 2007

Hadaschik, B. A., & Gleave, M. E. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.05.010 · Cited by 57 · see citing works

Molecular pathology of prostate cancer

Konishi, N., Shimada, K., Ishida, E., & Nakamura, M. (2005) · Pathology International · doi:10.1111/j.1440-1827.2005.01865.x · Cited by 53 · see citing works

Isoform-Specific Regulation of Uridine Diphosphate-Glucuronosyltransferase 2B Enzymes in the Human Prostate: Differential Consequences for Androgen and Bioactive Lipid Inactivation

Chouinard, S., Pelletier, G., Bélanger, A., & Barbier, O. (2006) · Endocrinology · doi:10.1210/en.2006-0229 · Cited by 53 · see citing works

Abiraterone and Novel Antiandrogens: Overcoming Castration Resistance in Prostate Cancer

Ferraldeschi, R., Pezaro, C. J., Karavasilis, V., & Bono, J. S. D. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-121211-091605 · Cited by 52 · see citing works

Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: Frequency of DD homozygotes increases with Gleason Score

Hajdinjak, T., & Zagradišnik, B. (2004) · The Prostate · doi:10.1002/pros.20024 · Cited by 51 · see citing works

Genomic organization of the UGT2b gene cluster on human chromosome 4q13

Riedy, M., Wang, J.-Y., Miller, A. P., Buckler, A., Hall, J., & Guida, M. (2000) · Pharmacogenetics · doi:10.1097/00008571-200004000-00006 · Cited by 49 · see citing works

Androgen Glucuronidation: An Unexpected Target for Androgen Deprivation Therapy, with Prognosis and Diagnostic Implications

Grosse, L., Pâquet, S., Caron, P., Fazli, L., Rennie, P. S., Bélanger, A., & Barbier, O. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1462 · Cited by 49 · see citing works

The transcriptional programme of the androgen receptor ( AR ) in prostate cancer

Lamb, A. D. G., Massie, C. E., & Neal, D. E. (2013) · British Journal of Urology · doi:10.1111/bju.12415 · Cited by 48 · see citing works

Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population

Okugi, H., Nakazato, H., Matsui, H., Ohtake, N., Nakata, S., & Suzuki, K. (2006) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2006.04.004 · Cited by 47 · see citing works

Modulation of the Human Glucuronosyltransferase UGT1A Pathway by Splice Isoform Polypeptides Is Mediated through Protein-Protein Interactions

Bellemare, J., Rouleau, M., Harvey, M., & Guillemette, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083139 · Cited by 47 · see citing works

Differential Expression of the Androgen-Conjugating UGT2B15 and UGT2B17 Enzymes in Prostate Tumor Cells during Cancer Progression

Pâquet, S., Fazli, L., Grosse, L., Verreault, M., Têtu, B., Rennie, P. S., Bélanger, A., & Barbier, O. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2064 · Cited by 44 · see citing works

Physiology of the prostate

Frick, J., & Aulitzky, W. (1991) · Infection · doi:10.1007/bf01643679 · Cited by 38 · see citing works

Mechanism of GnRH action in gonadotrophs

Clayton, R. N. (1988) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136732 · Cited by 36 · see citing works

Correlation between circulatory, local prostatic, and intra‐prostatic androgen levels

Olsson, M., Ekström, L., Guillemette, C., Bélanger, A., Rane, A., & Gustafsson, O. (2010) · The Prostate · doi:10.1002/pros.21307 · Cited by 35 · see citing works

Prostate Cancer with Variants in CYP17 and UGT2B17 Genes: A Meta-Analysis

Cai, L., Huang, W., & Chou, K. (2012) · Protein and Peptide Letters · doi:10.2174/092986612798472848 · Cited by 33 · see citing works

Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line

Guillemette, C., Hum, D. W., & Bèlanger, A. (1996) · Endocrinology · doi:10.1210/endo.137.7.8770908 · Cited by 32 · see citing works

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

El-Amm, J., Patel, N., Freeman, A. T., & Aragon‐Ching, J. B. (2013) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s11670 · Cited by 32 · see citing works

The Impact of Common Genetic Variations in Genes of the Sex Hormone Metabolic Pathways on Steroid Hormone Levels and Prostate Cancer Aggressiveness

Sun, T., Oh, W. K., Jacobus, S. J., Regan, M. M., Pomerantz, M. M., Freedman, M. L., Lee, G. M., & Kantoff, P. W. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0283 · Cited by 31 · see citing works

Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines

Bellemare, J., Rouleau, M., Harvey, M., Têtu, B., & Guillemette, C. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.64 · Cited by 30 · see citing works

Association of Uridine Diphosphate-Glucuronosyltransferase 2B Gene Variants with Serum Glucuronide Levels and Prostate Cancer Risk

Grant, D. J., Hoyo, C., Oliver, S., Gerber, L., Shuler, K., Calloway, E. E., Freedland, A. R., McPhail, M. E., Livingston, J. N., Richardson, R. M., et al. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0161 · Cited by 29 · see citing works

Alternatively Spliced Products of the UGT1A Gene Interact with the Enzymatically Active Proteins to Inhibit Glucuronosyltransferase Activity In Vitro

Bellemare, J., Rouleau, M., Girard, H., Harvey, M., & Guillemette, C. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.034835 · Cited by 26 · see citing works

New Therapeutics to Treat Castrate‐Resistant Prostate Cancer

Acar, Ö., Esen, T., & Lack, N. A. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/379641 · Cited by 25 · see citing works

Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation

Lévesque, É., Ménard, V., Laverdière, I., Bellemare, J., Barbier, O., Girard, H., & Guillemette, C. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328336ef1c · Cited by 25 · see citing works

Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study

Vidal, A. C., Tucker, C., Schildkraut, J. M., Richardson, R. M., McPhail, M. E., Freedland, S. J., Hoyo, C., & Grant, D. J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-556 · Cited by 24 · see citing works

Polymorphisms in androgen signaling pathway predisposing to prostate cancer

Schleutker, J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.007 · Cited by 23 · see citing works

UGT2B17 Polymorphism and Risk of Prostate Cancer: A Meta-Analysis

Kpoghomou, M.-A., Soatiana, J. E., Kalembo, F. W., Bishwajit, G., & Sheng, W. (2013) · ISRN Oncology · doi:10.1155/2013/465916 · Cited by 22 · see citing works

Nuclear receptors and endobiotics glucuronidation: the good, the bad, and the UGT

Bigo, C., Caron, S., Dallaire-Théroux, A., & Barbier, O. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.751992 · Cited by 21 · see citing works

Chemotherapy in the treatment of prostate cancer--is there a role?

Arianayagam, M., Chang, J., & Rashid, P. (2007) · PubMed · Cited by 6 · see citing works

The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms

Meech, R., Hu, D. G., McKinnon, R. A., Mubarokah, S. N., Haines, A. Z., Nair, P. C., Rowland, A., & Mackenzie, P. I. (2019) · Physiological Reviews · doi:10.1152/physrev.00058.2017 · Cited by 363 · see citing works

Intracrine androgen biosynthesis, metabolism and action revisited

Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217 · see citing works

Drug metabolizing enzymes and their inhibitors' role in cancer resistance

Pathania, S., Bhatia, R., Baldi, A., Singh, R., & Rawal, R. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.117 · Cited by 123 · see citing works

Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex

Bhatt, D. K., Basit, A., Zhang, H., Gaedigk, A., Lee, S., Claw, K. G., Mehrotra, A., Chaudhry, A. S., Pearce, R. E., Gaedigk, R., et al. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.080952 · Cited by 78 · see citing works

Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer

Lucarelli, G. T., Rutigliano, M., Galleggiante, V., Giglio, A., Palazzo, S., Ferro, M., Simone, C., Bettocchi, C., Battaglia, M., & Ditonno, P. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1069711 · Cited by 69 · see citing works

Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it

Verma, H., Bahia, M. S., Choudhary, S., Singh, P. K., & Silakari, O. (2019) · Drug Metabolism Reviews · doi:10.1080/03602532.2019.1632886 · Cited by 63 · see citing works

The UGTome: The expanding diversity of UDP glycosyltransferases and its impact on small molecule metabolism

Hu, D. G., Hulin, J.-A., Nair, P. C., Haines, A. Z., McKinnon, R. A., Mackenzie, P. I., & Meech, R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107414 · Cited by 55 · see citing works

Inverse Regulation of DHT Synthesis Enzymes 5α-Reductase Types 1 and 2 by the Androgen Receptor in Prostate Cancer

Audet‐Walsh, É., Yee, T., Tam, I. S., & Giguère, V. (2017) · Endocrinology · doi:10.1210/en.2016-1926 · Cited by 46 · see citing works

UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling

Li, H., Xie, N., Chen, R., Verreault, M., Fazli, L., Gleave, M. E., Barbier, O., & Dong, X. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1518 · Cited by 43 · see citing works

Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions

Mohammad, O. S., Nyquist, M. D., Schweizer, M. T., Balk, S. P., Corey, E., Plymate, S. R., Nelson, P. S., & Mostaghel, E. A. (2017) · Cancers · doi:10.3390/cancers9120166 · Cited by 42 · see citing works

The Uridine diphosphate (UDP)-glycosyltransferases (UGTs) superfamily: the role in tumor cell metabolism

Liu, W., Li, J., Zhao, R., Lu, Y., & Huang, P. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1088458 · Cited by 42 · see citing works

Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression

Zhang, A., Zhang, J., Plymate, S. R., & Mostaghel, E. A. (2016) · Hormones and Cancer · doi:10.1007/s12672-016-0250-9 · Cited by 42 · see citing works

Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer

Margaillan, G., Lévesque, É., & Guillemette, C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.09.021 · Cited by 41 · see citing works

Steroid metabolism in breast cancer: Where are we and what are we missing?

Africander, D., & Storbeck, K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.016 · Cited by 39 · see citing works

The relationship between UGT1A1 gene & various diseases and prevention strategies

Liu, D., Yu, Q., Ning, Q. X., Liu, Z., & Song, J. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.2001493 · Cited by 34 · see citing works

Bioassay-guided isolation of dehydrocostus lactone from Saussurea lappa: A new targeted cytosolic thioredoxin reductase anticancer agent

Yang, M., Zhang, J., Li, Y., Han, X., Gao, K., & Fang, J. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.08.008 · Cited by 31 · see citing works

Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4- d ][1,2,3]triazine derivatives

Nasr, T., Bondock, S., Youns, M., Fayad, W., & Zaghary, W. A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.016 · Cited by 31 · see citing works

A homozygous mutation of GNRHR in a familial case diagnosed with polycystic ovary syndrome

Caburet, S., Beck‐Fruchter, R., Legois, B., Fellous, M., Shalev, S. A., & Veitia, R. A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0968 · Cited by 27 · see citing works

Intracrinology-revisited and prostate cancer

Penning, T. M., & Detlefsen, A. J. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105499 · Cited by 22 · see citing works

New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation

Gunduz, M., Argikar, U. A., Cirello, A. L., & Dumouchel, J. L. (2018) · Drug Metabolism Letters · doi:10.2174/1872312812666180611113656 · Cited by 19 · see citing works

Posttranscriptional regulation of uridine diphosphate glucuronosyltransferases

Riches, Z., & Collier, A. C. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1028355 · Cited by 16 · see citing works

Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cells

Jiang, T., Zheng, L., Jiang, H., Zhang, Z., Wang, K., Wang, Q., & Li, Q. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s92129 · Cited by 16 · see citing works

New insights into the androgen biotransformation in prostate cancer: A regulatory network among androgen, androgen receptors and UGTs

Qin, X., Liu, M., & Wang, X. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.021 · Cited by 16 · see citing works

UDP-Glucuronosyltransferase 1A Determinates Intracellular Accumulation and Anti-Cancer Effect of β-Lapachone in Human Colon Cancer Cells

Liu, H., Li, Q., Cheng, X., Wang, H., Wang, G., & Hao, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117051 · Cited by 15 · see citing works

Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells

Shafiee-Kermani, F., Carney, S. T., Jima, D. D., Utin, U. C., Farrar, L. B., Oputa, M. O., Hines, M. R., Kinyamu, H. K., Trotter, K. W., Archer, T., et al. (2020) · Epigenetics · doi:10.1080/15592294.2020.1795601 · Cited by 13 · see citing works

Potent inhibition of tributyltin (TBT) and triphenyltin (TPT) against multiple UDP-glucuronosyltransferases (UGT): A new potential mechanism underlying endocrine disrupting actions

Lv, H., Wang, J., Wang, M., Shen, L., Xiao, L., Chen, T., Sun, T., Li, W., Zhu, L., & Zhang, X. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112039 · Cited by 13 · see citing works

Relevance of Human Aldoketoreductases and Microbial β-Glucuronidases in Testosterone Disposition

Basit, A., Amory, J. K., Mettu, V. S., Li, C. Y., Heyward, S. A., Jariwala, P. B., Redinbo, M. R., & Prasad, B. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000975 · Cited by 13 · see citing works

Steroid sulfates in domestic mammals and laboratory rodents

Schuler, G. C. (2021) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2021.106622 · Cited by 13 · see citing works

Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study

Habibi, M., Mirfakhraie, R., Khani, M., Rakhshan, A., Azargashb, E., & Pouresmaeili, F. (2017) · Gene · doi:10.1016/j.gene.2017.08.038 · Cited by 12 · see citing works

Sequence-Based Analysis of Lipid-Related Metabolites in a Multiethnic Study

Feofanova, E. V., Yu, B., Metcalf, G., Liu, X., Muzny, D. M., Below, J. E., Wagenknecht, L. E., Gibbs, R. A., Morrison, A. C., & Boerwinkle, E. (2018) · Genetics · doi:10.1534/genetics.118.300751 · Cited by 12 · see citing works

LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR?

Cariello, M., Ducheix, S., Maqdasy, S., Baron, S., Moschetta, A., & Lobaccaro, J. A. (2018) · Nuclear Receptor Signaling · doi:10.1177/1550762918801070 · Cited by 11 · see citing works

AKR1C3 mediates pan‐AR antagonist resistance in castration‐resistant prostate cancer

Hertzog, J., Zhang, Z., Bignan, G., Connolly, P. J., Heindl, J. E., Janetopoulos, C., Rupnow, B. A., & McDevitt, T. M. (2020) · The Prostate · doi:10.1002/pros.24049 · Cited by 10 · see citing works

Canonical and Noncanonical Androgen Metabolism and Activity

Storbeck, K., & Mostaghel, E. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_11 · Cited by 10 · see citing works

UDP-glucuronosyltransferase Enzymes in Prostate Cancer Progression: Is Only Androgen Catabolism Involved?

Mostaghel, E. A., Zhang, A., & Plymate, S. R. (2015) · European Urology · doi:10.1016/j.eururo.2015.08.025 · Cited by 10 · see citing works

Heritability of serum dehydroepiandrosterone sulphate levels and pubertal development in 6∼18-year-old girls: a twin study

Li, H., Ji, C.-Y., Liu, Y., & Zhuang, C. (2016) · Annals of Human Biology · doi:10.1080/03014460.2016.1240232 · Cited by 9 · see citing works

Exemestane and Its Active Metabolite 17-Hydroexemestane Induce UDP-Glucuronosyltransferase (UGT) 2B17 Expression in Breast Cancer Cells

Chanawong, A., Mackenzie, P. I., McKinnon, R. A., Hu, D. G., & Meech, R. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.240317 · Cited by 9 · see citing works

Regulation of Hepatic UGT2B15 by Methylation in Adults of Asian Descent

Oeser, S. G., Bingham, J., & Collier, A. C. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010006 · Cited by 8 · see citing works

Androgen Receptor/AP-1 Activates UGT2B15 Transcription to Promote Esophageal Squamous Cell Carcinoma Invasion

Cai, J., Huang, F., Gao, W., Gong, T., Chen, H., & Liu, Z. (2023) · Cancers · doi:10.3390/cancers15245719 · Cited by 7 · see citing works

Genetic and molecular determinants of prostate cancer among Iranian patients: An update

Ghayour‐Mobarhan, M., Ferns, G. A., & Moghbeli, M. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1657061 · Cited by 7 · see citing works

Naftopidil enantiomers suppress androgen accumulation and induce cell apoptosis via the UDP-glucuronosyltransferase 2B15 in benign prostate hyperplasia

Zhan, H., Zhang, S., Li, L., Chen, Z., Cai, Y., Huang, J., Wu, D., Huang, B., Wu, B., & Liu, X. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106117 · Cited by 6 · see citing works

Revisiting the roles of cAMP signalling in the progression of prostate cancer

Parsons, E. C., Hoffmann, R., & Baillie, G. S. (2023) · Biochemical Journal · doi:10.1042/bcj20230297 · Cited by 6 · see citing works

Intracrine androgen biosynthesis and drug resistance

Penning, T. M., Asangani, I. A., Sprenger, C. C. T., & Plymate, S. R. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.60 · Cited by 6 · see citing works

Crystal structures and Hirshfeld surface analyses of the hemi-hydrate and hemi-methanolate of 3α-hydroxy-16α-bromoandrostan-17-one, 3: Differences in supramolecular arrangements

Gomes, L. R., Low, J. N., Turner, A. B., & Wardell, J. L. (2018) · Steroids · doi:10.1016/j.steroids.2018.07.005 · Cited by 4 · see citing works

Crystal structures and Hirshfeld surface analyses of the di- and tri-hydrates of (5α,17E)-17-hydrazonoandrostan-3-ol: Significant differences in the hydrogen bonding patterns and supramolecular arrangements

Gomes, L. R., Low, J. N., Turner, A. B., Baddeley, T. C., & Wardell, J. L. (2018) · Steroids · doi:10.1016/j.steroids.2018.09.010 · Cited by 4 · see citing works

Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancer

Nie, M., Li, T., Liu, P., & Wang, X. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09917-4 · Cited by 4 · see citing works

Potential Antitumor Mechanism of Propolis Against Skin Squamous Cell Carcinoma A431 Cells Based on Untargeted Metabolomics

Wang, J., Cheng, L., Li, J., Wang, Y., Chen, S., Wang, Z., & Yang, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011265 · Cited by 3 · see citing works

Androgen metabolism genes in prostate cancer health disparities.

Liu, W., Liu, R., & Wang, L. (2017) · PubMed · doi:10.9777/rr.2017.10003 · Cited by 3 · see citing works

Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trial

Ho, V., Pasquet, R., Luo, S., Chen, G., Goss, P. E., Tu, D., Lazarus, P. J., Richardson, H., & on behalf of the MAP3 Investigators (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05812-1 · Cited by 3 · see citing works

Scaffold attachment factor B1 regulates androgen degradation pathways in prostate cancer.

Yang, J., Chen, Q., You, S., Rotinen, M., Posadas, E. M., Freedland, S. J., Vizio, D. D., Kim, J., & Freeman, M. R. (2021) · Europe PMC (PubMed Central) · Cited by 3 · see citing works

What can we learn from the history of steroid metabolites and the ongoing identification of novel biologically active steroid metabolites?

Odermatt, A., & Morris, D. J. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.106954 · Cited by 2 · see citing works

Androgen Glucuronidation in Mice: When, Where, and How

Grosse, L., Chouinard, S., Pâquet, S., Verreault, M., Trottier, J., Bélanger, A., & Barbier, O. (2022) · Biology · doi:10.3390/biology11030403 · Cited by 2 · see citing works

Testosterone and epitestosterone differentially regulate UDP-glucuronosyltransferases (UGT) activity

Xiao, L., Qi, J., Zhang, Y., Li, W., 朱亮亮, & Liang, S. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.107058 · Cited by 1 · see citing works

Influence of polymorphisms of UDP-glycosyltransferases (UGT) 2B family genes UGT2B15, UGT2B17 and UGT2B28 on the development of prostate cancer in Korean men

Lee, S.-R., Ahn, M.-H., Choi, Y. H., & Leem, S. (2015) · Genes & Genomics · doi:10.1007/s13258-015-0379-x · Cited by 1 · see citing works

Molecular modeling study of the testosterone metabolizing enzyme UDP-glucuronosyltransferase 2B17

Trane, I., Sager, G., Dietrichs, E. S., & Ravna, A. W. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116060 · Cited by 1 · see citing works

CELL MODELS FOR STUDYING THE INTERPLAY BETWEEN CONJUGATIVE METABOLISM AND EFFLUX TRANSPORTERS: ESTABLISHING UGT1A1, UGT2B7 AND MRP3 TRANSFECTED MDCK CELL LINES

Järvinen, E. (2016) · Työväentutkimus Vuosikirja

Characteristics Of Androgen Metabolism In Prostate Diseases

Roussev, B. H., & Galunska, B. T. (2018) · Varna Medical Forum · doi:10.14748/vmf.v7i2.5137

[Advances in medical therapy of hypertension].

Orbegozo, J. M. R. (1953) · PubMed

The structural basis of conserved residue variant effect on enzyme activity of UGT2B15

Zhang, L., Zhang, X., Yang, Y., Gu, J., Liu, Z., & Wang, C. (2023) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2023.140888

Rs10046, Rs1902023, Rs4148269 and Ugt2b17 Deletion in Tunisian Women's Hormone Receptor Positivebreast Cancer: Risk Factors and PrognosticPreprint

Zid, Z., Gara, S., & Kharrat, M. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4665826

Drug metabolism in cancer patients

Huang, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29289-7.00024-2

Exploring chemoresistance mechanisms and innovative drug delivery approaches in effective cancer therapy

Priyadarshi, K., & Rao, T. S. R. B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45717-3.00008-8

Inactivation by UDP-glucuronosyltransferase enzymes: The end of androgen signaling

Chouinard, S., Yueh, M.-F., Tukey, R. H., Giton, F., Fiet, J., Pelletier, G., Barbier, O., & Bélanger, A. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.03.016 · Cited by 90 · see citing works

Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate

Barbier, O., & Bélanger, A. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.01.001 · Cited by 86 · see citing works

UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells

Chouinard, S., Barbier, O., & Bélanger, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703370200 · Cited by 109 · see citing works

Cellular Specific Expression of the Androgen‐Conjugating Enzymes UGT2B15 and UGT2B17 in the Human Prostate Epithelium

Chouinard, S., Pelletier, G., Bélanger, A., & Barbier, O. (2004) · Endocrine Research · doi:10.1081/erc-200044014 · Cited by 57 · see citing works

Androgen Glucuronidation: An Unexpected Target for Androgen Deprivation Therapy, with Prognosis and Diagnostic Implications

Grosse, L., Pâquet, S., Caron, P., Fazli, L., Rennie, P. S., Bélanger, A., & Barbier, O. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1462 · Cited by 49 · see citing works